Skip to main content

Table 1 Measures and assessment points used in the study

From: Effectiveness of EMDR in patients with substance use disorder and comorbid PTSD: study protocol for a randomized controlled trial

Variable Measure Assessment method T0 Baseline T1 Post treatment T2 3 months T3 6 months
SUD diagnosis IDCL [31] interview x x x x
PTSD diagnosis CAPS [33] interview x x x x
PTSD symptoms CAPS [33] interview x x x x
Early traumatic experiences CTQ [46] self-report x x x x
Substance use AUDIT [37]/DUDIT [40] TLFB [41] interview x x x x
Addiction-related problems ASI-Lite [42] interview x x x x
Dissociative symptoms DES [25] self-report x x x x
Depressive symptoms BDI-II [43] self-report x x x x
Emotion dysregulation DERS [44] self-report x x x x
Quality of life SF-12 [45] self-report x x x x
Safety SAE Report Form self-report ---------------- x x
  1. Notes. IDCL International Diagnostic Checklists. CAPS Clinician-Administered PTSD Scale. CTQ Childhood Trauma Questionnaire. AUDIT Alcohol Use Disorders Identification Test. DUDIT Drug Use Disorders Identification Test. TLFB Timeline Follow Back. ASI-Lite Addiction Severity Index-Lite. DES Dissociative Experience Scale. BDI-II Beck Depression Inventory-II. DERS Difficulties in Emotion Regulation Scale. SF-12 Short-Form 12-Item Health Survey. SAE Serious Adverse Event